Transplantation in Parkinson's disease: Two cases of adrenal medullary grafts to the putamen
The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
Autologous adrenal medullary tissue was transplanted unilaterally to the putamen in two patients with severe Parkinson's disease. The first patient exhibited a transient, two‐day improvement of motor performance in the limbs contralateral to the implantation site. He also had significantly longer episodes of normal function for about two months. The second patient reported a minor improvement of balance and gait, again lasting for two months. Electrophysiological studies of the motor readiness and auditory evoked potentials were consistent with increased catecholaminergic activity in the basal ganglia after transplantation in both patients. Positron emission tomography showed no postoperative alteration of receptor density in the putamen. No significant adverse effects of the transplantation were observed in the patients' performance on neurological and psychological tests or in their quantitative electroencephalogram and cerebral blood flow recordings. Immediately after the grafting, one patient showed transient signs of sympathetic hyperactivity, probably caused by release of catecholamines from the implanted tissue into the peripheral circulation. We conclude that catecholamine‐rich cellular implants in the basal ganglia have transient beneficial effects in patients with severe Parkinson's disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Parkinsonism: onset, progression, and mortality
Hoehn, M. M., & Yahr, M. D. (1967) · Neurology · doi:10.1212/wnl.17.5.427 · Cited by 12,107
Electrical Signs of Selective Attention in the Human Brain
Hillyard, S. A., Hink, R. F., Schwent, V. L., & Picton, T. W. (1973) · Science · doi:10.1126/science.182.4108.177 · Cited by 1,934
Kornhuber, H. H., & Deecke, L. (1965) · Pfl�gers Archiv f�r die Gesamte Physiologie des Menschen und der Tiere · doi:10.1007/bf00412364 · Cited by 1,907
The Measurement and Appraisal of Adult Intelligence (4th ed.).
Wechsler, D. (1958) · doi:10.1037/11167-000 · Cited by 1,683
Brain Grafts Reduce Motor Abnormalities Produced by Destruction of Nigrostriatal Dopamine System
Perlow, M. J., Freed, W. J., Hoffer, B. J., Seiger, A., Olson, L., & Wyatt, R. J. (1979) · Science · doi:10.1126/science.571147 · Cited by 966
Self-citationThe mysterious motor function of the basal ganglia: The Robert Wartenberg Lecture
Marsden, C. D. (1982) · Neurology · doi:10.1212/wnl.32.5.514 · Cited by 920
Regional Cerebral Blood Flow Estimated by 133 Xenon Inhalation
OBRIST, W. D., THOMPSON, H. K., WANG, H. S., & WILKINSON, W. E. (1975) · Stroke · doi:10.1161/01.str.6.3.245 · Cited by 859
Quantitative Analysis of D2 Dopamine Receptor Binding in the Living Human Brain by PET
Farde, L., Hall, H., Ehrin, E., & Sedvall, G. (1986) · Science · doi:10.1126/science.2867601 · Cited by 831
Self-citationReconstruction of the nigrostriatal dopamine pathway by intracerebral nigral transplants
Bjo¨rklund, A., & Stenevi, U. (1979) · Brain Research · doi:10.1016/0006-8993(79)90472-4 · Cited by 830
The Prevention of Acute Gastric Ulcer in the Rat by α-Methyldopa
Djahanguiri, B., Hemmati, S., Sadeghi, D., & Firouzabadi, A. (1967) · Pharmacology · doi:10.1159/000137111 · Cited by 783
Cited by
Grafts of Fetal Dopamine Neurons Survive and Improve Motor Function in Parkinson's Disease
Lindvall, O., Brundin, P., Widner, H., Rehncrona, S., Gustavii, B., Frackowiak, R., Leenders, K. L., Sawle, G., Rothwell, J. C., Marsden, C. D., et al. (1990) · Science · doi:10.1126/science.2105529 · Cited by 1,207
Self-citationPersonalized iPSC-Derived Dopamine Progenitor Cells for Parkinson’s Disease
Schweitzer, J. S., Song, B., Herrington, T. M., Park, T.-Y., Lee, N., Ko, S., Jeon, J., Cha, Y., Kim, K., Li, Q., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1915872 · Cited by 542
Lindvall, O. (1989) · Archives of Neurology · doi:10.1001/archneur.1989.00520420033021 · Cited by 535
Self-citationNerve growth factor: from the early discoveries to the potential clinical use
Aloe, L., Rocco, M. L., Bianchi, P., & Manni, L. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-239 · Cited by 457
Fetal Nigral Transplantation as a Therapy for Parkinson’s Disease
Olanow, C. W., & Fahn, S. (2006) · Restorative Therapies in Parkinson’s Disease · doi:10.1007/0-387-32823-8_6 · Cited by 412
Lindvall, O., Widner, H., Rehncrona, S., Brundin, P., Odin, P., Gustavii, B., Frackowiak, R., Leenders, K. L., Sawle, G., Rothwell, J. C., et al. (1992) · Annals of Neurology · doi:10.1002/ana.410310206 · Cited by 358
Self-citationCell-based therapies for Parkinson disease—past insights and future potential
Barker, R. A., Drouin-Ouellet, J., & Parmar, M. (2015) · Nature Reviews Neurology · doi:10.1038/nrneurol.2015.123 · Cited by 306
Widner, H., & Brundin, P. (1988) · Brain Research Reviews · doi:10.1016/0165-0173(88)90010-0 · Cited by 287
Brundin, P., Strecker, R. E., Widner, H., Clarke, D. J., Nilsson, O. G., Åstedt, B., Lindvall, O., & Björklund, A. (1988) · Experimental Brain Research · doi:10.1007/bf00271860 · Cited by 278
Self-citationAtrophy of medium spiny I striatal dendrites in advanced Parkinson's disease
McNeill, T. H., Brown, S. A., Rafols, J. A., & Shoulson, I. (1988) · Brain Research · doi:10.1016/0006-8993(88)90124-2 · Cited by 246
Transplantation of Human Fetal Dopamine Cells for Parkinson's Disease: Results at 1 Year
Freed, C. R. (1990) · Archives of Neurology · doi:10.1001/archneur.1990.00530050021007 · Cited by 242
Metadata
- Authors
- Lindvall, O., Backlund, E., Farde, L., Sedvall, G., Freedman, R., Hoffer, B., Nobin, A., Seiger, Å., & Olson, L.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 1987-10
- Volume
- 22
- Issue
- 4
- Pages
- 457-468
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2014508565
- Cited by
- 277
- References
- 38
- FWCI
- 35.35
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.